U-Neuron Biomedical Inc (TPEX:6973)
Taiwan · Delayed Price · Currency is TWD 58.00
+0.60 (1.05%)
Oct 30, 2026, 1:31 PM CST
U-Neuron Biomedical Market Cap
U-Neuron Biomedical has a market cap or net worth of 1.71 billion as of October 30, 2026. It is the 29,740th most valuable company in the world and the 1,750th biggest in Taiwan. Its market cap has increased by 38.10% in one year.
Market Cap
1.71B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,750 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 20, 2023, U-Neuron Biomedical's market cap has increased from 1.36B to 1.71B, an increase of 26.09%. That is a compound annual growth rate of 7.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.71B | 53.03% |
| Dec 31, 2025 | 1.12B | -9.44% |
| Dec 31, 2024 | 1.24B | -30.25% |
| Dec 29, 2023 | 1.77B | 30.43% |
| Jul 20, 2023 | 1.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3D Global Biotech | 2.15B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.03B |
| Sunhawk Vision Biotech | 2.00B |
| G&E Herbal Biotechnology | 1.83B |
| Sunny Pharmtech | 1.58B |
| Anti-Microbial Savior BioteQ | 1.57B |
| Greenyn Biotechnology | 1.56B |
| Synbio Tech | 1.56B |